Early cancer detection company Oncimmune Holdings issued an update to the market on is business on Tuesday, ahead of the announcement of interim results expected on 13 February. The AIM-traded firm said that, since the publication of its full year results in October, it continued to make "good progress" against its commercialisation plans. On its EarlyCDT-Lung product, the board said it commenced a marketing programme in the US to support its distributors. "However, as stated in our results we ...Den vollständigen Artikel lesen ...
© 2018 LiveCharts.co.uk
